Picture of Black Diamond Therapeutics logo

BDTX Black Diamond Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Black Diamond Therapeutics Announces Strategic Priorities And Expected Milestones For 2022

Jan 10 (Reuters) - Black Diamond Therapeutics Inc  BDTX.O :
    * BLACK DIAMOND THERAPEUTICS ANNOUNCES STRATEGIC PRIORITIES AND EXPECTED
MILESTONES FOR 2022
    * BLACK DIAMOND THERAPEUTICS INC - ANTICIPATES INITIATION OF IND-ENABLING
STUDIES
FOR ITS CNS-PENETRANT CLASS I,II,III BRAF PROGRAM IN 2022
    * BLACK DIAMOND THERAPEUTICS INC - CASH RUNWAY EXTENDED TO 2024

Source text for Eikon:  ID:nGNX1dvYMr 
Further company coverage:  BDTX.O

Recent news on Black Diamond Therapeutics

See all news